Lallemand Pharma and Stada Cis Join forces to launch Ismigen in Russia

LALLEMAND PHARMA and STADA CIS are pleased to announce the launch on the Russian market of PMBL™ tablets, an immuno-modulating drug developed and produced by Lallemand Pharma and distributed in Russia by STADA CIS under tradename ISMIGEN®. ISMIGEN®is recommended in the prevention of acute, sub-acute, recurrent or chronic infections of the upper and lower airways and the bronchopulmonary tree in adults and children.

The release as fetched from its publisher. lallemandpharma.com ↗